EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome

Rajesh Kumar, Samantha Milanesi, Martyna Szpakowska, Laura Dotta, Dario Di Silvestre, Anna Maria Trotta, Anna Maria Bello, Mauro Giacomelli, Manuela Benedito, Joana Azevedo, Alexandra Pereira, Emilia Cortesao und 10 weitere

JCI Insight · 2023

DOI: 10.1172/jci.insight.145688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Rajesh Kumar und 21 weiteren Autor:innen. Beteiligte Einrichtung: "Angelo Nocivelli" Institute for Molecular Medicine, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: beta-Arrestins, GTP-Binding Proteins, Primary Immunodeficiency Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministery of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

WHIM syndrome is an inherited immune disorder caused by an autosomal dominant heterozygous mutation in CXCR4. The disease is characterized by neutropenia/leukopenia (secondary to retention of mature neutrophils in bone marrow), recurrent bacterial infections, treatment-refractory warts, and hypogammaglobulinemia. All mutations reported in WHIM patients lead to the truncations in the C-terminal domain of CXCR4, R334X being the most frequent. This defect prevents receptor internalization and enhances both calcium mobilization and ERK phosphorylation, resulting in increased chemotaxis in response to the unique ligand CXCL12. Here, we describe 3 patients presenting neutropenia and myelokathexis, but normal lymphocyte count and immunoglobulin levels, carrying what we believe to be a novel Leu317fsX3 mutation in CXCR4, leading to a complete truncation of its intracellular tail. The analysis of the L317fsX3 mutation in cells derived from patients and in vitro cellular models reveals unique signaling features in comparison with R334X mutation. The L317fsX3 mutation impairs CXCR4 downregulation and β-arrestin recruitment in response to CXCL12 and reduces other signaling events — including ERK1/2 phosphorylation, calcium mobilization, and chemotaxis — all processes that are typically enhanced in cells carrying the R334X mutation. Our findings suggest that, overall, the L317fsX3 mutation may be causative of a form of WHIM syndrome not associated with an augmented CXCR4 response to CXCL12.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ArrestinsGTP-Binding ProteinsPrimary Immunodeficiency DiseasesHumansbeta-Arrestin 1CalciumMAP Kinase Signaling SystemMutationNeutropeniaSignal TransductionWartsChemokine CXCL12Receptors, CXCR4Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3

Stichwörter der Autor:innen

Cell BiologyChemokinesImmunologySignal transduction

Substanzen

beta-Arrestin 1beta-ArrestinsCalciumGTP-Binding ProteinsCXCL12 protein, humanChemokine CXCL12CXCR4 protein, humanReceptors, CXCR4MAPK1 protein, humanMitogen-Activated Protein Kinase 1

Autor:innen und Institutionen

  • "Angelo Nocivelli" Institute for Molecular Medicine, University of Brescia, Brescia, Italy.
  • Rheumatology and Clinical Immunology, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili, Brescia, Italy.
  • Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Department of Pediatrics, ASST Spedali Civili, Brescia, Italy.

Förderung

  • Italian Ministery of Health

Zitieren

APA

Kumar, R., Milanesi, S., Szpakowska, M., Dotta, L., Di Silvestre, D., Trotta, A. M., Bello, A. M., Giacomelli, M., Benedito, M., Azevedo, J., Pereira, A., Cortesao, E., Vacchini, A., Castagna, A., Pinelli, M., Moratto, D., Bonecchi, R., Locati, M., Scala, S., …, & Badolato, R. (2023). Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome. JCI Insight. https://doi.org/10.1172/jci.insight.145688

Vancouver

Kumar R, Milanesi S, Szpakowska M, Dotta L, Di Silvestre D, Trotta AM, et al. Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome. JCI Insight. 2023. doi:10.1172/jci.insight.145688

BibTeX
@article{Kumar2023,
  author = {Kumar, Rajesh and Milanesi, Samantha and Szpakowska, Martyna and Dotta, Laura and Di Silvestre, Dario and Trotta, Anna Maria and Bello, Anna Maria and Giacomelli, Mauro and Benedito, Manuela and Azevedo, Joana and Pereira, Alexandra and Cortesao, Emilia and Vacchini, Alessandro and Castagna, Alessandra and Pinelli, Marinella and Moratto, Daniele and Bonecchi, Raffaella and Locati, Massimo and Scala, Stefania and Chevigné, Andy and Borroni, Elena M and Badolato, Raffaele},
  title = {Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome},
  journal = {JCI Insight},
  year = {2023},
  doi = {10.1172/jci.insight.145688}
}
Kostenlos starten →